Pretreatment with Erythropoietin Attenuates Lung Ischemia/Reperfusion Injury via Toll-Like Receptor-4/Nuclear Factor-κB (TLR4/NF-κB) Pathway
暂无分享,去创建一个
Yu Cao | Siwei Bi | Qian He | Xueshan Zhao
[1] L. Wan,et al. A Novel Chinese Medicine, Xinfeng Capsule, Modulates Proinflammatory Cytokines via Regulating the Toll-Like Receptor 4 (TLR4)/Mitogen-Activated Protein Kinase (MAPK)/Nuclear Kappa B (NF-κB) Signaling Pathway in an Adjuvant Arthritis Rat Model , 2019, Medical science monitor : international medical journal of experimental and clinical research.
[2] Zhen Jin,et al. miR-27a suppresses TLR4-induced renal ischemia-reperfusion injury , 2019, Molecular medicine reports.
[3] C. Holmes,et al. Novel, selective EPO receptor ligands lacking erythropoietic activity reduce infarct size in acute myocardial infarction in rats. , 2016, Pharmacological research.
[4] Weixi Zhang,et al. Resolvin D1 Alleviates the Lung Ischemia Reperfusion Injury via Complement, Immunoglobulin, TLR4, and Inflammatory Factors in Rats , 2016, Inflammation.
[5] N. Zhang,et al. Erythropoietin Protects Rat Brain Injury from Carbon Monoxide Poisoning by Inhibiting Toll-Like Receptor 4/NF-kappa B-Dependent Inflammatory Responses , 2016, Inflammation.
[6] M. Mulligan,et al. Role of toll-like receptor-4 in lung ischemia-reperfusion injury. , 2015, The Annals of thoracic surgery.
[7] X. Ji,et al. Erythropoietin Delivered via Intra-Arterial Infusion Reduces Endoplasmic Reticulum Stress in Brain Microvessels of Rats Following Cerebral Ischemia and Reperfusion , 2015, Journal of Neuroimmune Pharmacology.
[8] N. El-Maraghy,et al. Candesartan and glycyrrhizin ameliorate ischemic brain damage through downregulation of the TLR signaling cascade. , 2014, European journal of pharmacology.
[9] Y. Le,et al. Toll-like receptors in inflammation of the central nervous system. , 2011, International immunopharmacology.
[10] G. Remuzzi,et al. Erythropoietin enhances immunostimulatory properties of immature dendritic cells , 2011, Clinical and experimental immunology.
[11] Biao Xu,et al. Erythropoietin attenuates ischemia-reperfusion induced lung injury by inhibiting tumor necrosis factor-alpha and matrix metalloproteinase-9 expression. , 2009, European journal of pharmacology.
[12] B. Lambrecht,et al. Ischemia of the lung causes extensive long-term pulmonary injury: an experimental study , 2008, Respiratory research.
[13] Biao Xu,et al. Pretreatment with recombined human erythropoietin attenuates ischemia-reperfusion-induced lung injury in rats. , 2006, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[14] R. Medzhitov,et al. Inducible Activation of TLR4 Confers Resistance to Hyperoxia-Induced Pulmonary Apoptosis , 2006, The Journal of Immunology.
[15] Y. Vodovotz,et al. Hemorrhagic shock-activated neutrophils augment TLR4 signaling-induced TLR2 upregulation in alveolar macrophages: role in hemorrhage-primed lung inflammation. , 2006, American journal of physiology. Lung cellular and molecular physiology.
[16] R. Homer,et al. Cutting Edge: TLR4 deficiency confers susceptibility to lethal oxidant lung injury. , 2005, The Journal of Immunology.
[17] G. Prestwich,et al. Regulation of lung injury and repair by Toll-like receptors and hyaluronan , 2005, Nature Medicine.
[18] J. Oppenheim,et al. Alarmins: chemotactic activators of immune responses. , 2005, Current opinion in immunology.
[19] K. Matschke,et al. Protection against acute porcine lung ischemia/reperfusion injury by systemic preconditioning via hind limb ischemia , 2005, Transplant international : official journal of the European Society for Organ Transplantation.
[20] T. D’amico,et al. Acute Lung Injury and Acute Respiratory Distress Syndrome After Pulmonary Resection , 2004, Seminars in cardiothoracic and vascular anesthesia.
[21] W. Jelkmann,et al. Beneficial and ominous aspects of the pleiotropic action of erythropoietin , 2004, Annals of Hematology.
[22] H. Schäfers,et al. Cytokine response to pulmonary thromboendarterectomy. , 2004, Chest.
[23] S. Keshavjee,et al. Ischemia-reperfusion-induced lung injury. , 2003, American journal of respiratory and critical care medicine.
[24] P. Ghezzi,et al. Erythropoietin exerts an anti-inflammatory effect on the CNS in a model of experimental autoimmune encephalomyelitis , 2002, Brain Research.
[25] A. Arifi,et al. Pulmonary dysfunction after cardiac surgery. , 2002, Chest.
[26] S. Akira,et al. Toll-like receptors: critical proteins linking innate and acquired immunity , 2001, Nature Immunology.
[27] G. Diamond,et al. The innate immune response of the respiratory epithelium , 2000, Immunological reviews.
[28] J. Zhang,et al. Erythropoietin Receptor Activation Protects the Kidney From Ischemia/Reperfusion-Induced Apoptosis by Activating ERK/p53 Signal Pathway. , 2016, Transplantation proceedings.
[29] U. Francisco. Lung Ischemia-Reperfusion is a Sterile Inflammatory Process Influenced by Commensal Microbiota in Mice , 2015 .
[30] A. Arifi,et al. Inflammatory Response to Pulmonary Ischemia–Reperfusion Injury , 2005, Surgery Today.
[31] B. Gaston,et al. Tumor necrosis factor-alpha from resident lung cells is a key initiating factor in pulmonary ischemia-reperfusion injury. , 2004, The Journal of thoracic and cardiovascular surgery.
[32] M. Gassmann,et al. Non-erythroid functions of erythropoietin. , 2003, Advances in experimental medicine and biology.